Banerjee [30] already reported that tumor-derived IL6 is able to mediate an epigenetic silencing of DNA damage repair and reactive oxygen-metabolism genes in prostate fibroblasts, ultimately resulting in DNA-damage associated secretory phenotype, characterized by H3 lysine 9 trimethylation and TGFBR2 down-regulation. This evidence concerns the gene IL6 and neoplasm.